atorvastatin has been researched along with iloprost in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Kinsella, BT; O'Meara, SJ | 1 |
| Araújo, AC; Jorge, VC; Noronha, C; Panarra, A; Riso, N; Vaz Riscado, M | 1 |
3 other study(ies) available for atorvastatin and iloprost
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Effect of the statin atorvastatin on intracellular signalling by the prostacyclin receptor in vitro and in vivo.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adenylyl Cyclases; Animals; Atorvastatin; Blood Platelets; Bridged Bicyclo Compounds, Heterocyclic; Calcium; Cell Line; Cell Line, Tumor; Cholesterol; Clinical Trials as Topic; Cyclic AMP; Drug Evaluation, Preclinical; Fatty Acids, Unsaturated; Female; Heptanoic Acids; Humans; Hydantoins; Hydrazines; Iloprost; Ireland; Lipids; Male; Mice; Middle Aged; Propanolamines; Protein Prenylation; Pyrroles; Radioligand Assay; Receptor Cross-Talk; Receptors, Epoprostenol; Receptors, Immunologic; Receptors, Prostaglandin; Signal Transduction; Tritium | 2004 |
Buerger's disease (Thromboangiitis obliterans): a diagnostic challenge.
Topics: Adult; Angiography; Aspirin; Atorvastatin; Calcium Channel Blockers; Drug Therapy, Combination; Heparin, Low-Molecular-Weight; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Iloprost; Male; Nifedipine; Pentoxifylline; Platelet Aggregation Inhibitors; Pyrroles; Smoking Cessation; Thromboangiitis Obliterans | 2011 |